{"id":17088,"date":"2020-01-28T11:02:45","date_gmt":"2020-01-28T10:02:45","guid":{"rendered":"http:\/\/mabdesign.fr\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/"},"modified":"2020-01-28T11:02:45","modified_gmt":"2020-01-28T10:02:45","slug":"cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/","title":{"rendered":"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases"},"content":{"rendered":"

Cynbiose<\/strong><\/a>, a service company specializing in the development and commercialization of innovative preclinical models, today announces that it has procured financing of \u20ac1.9 million ($2.1M) under the third phase of the French Program \u2018Investment for the Future\u2019 (PiA3). These funds will make it possible to launch CYNBIOME, the first excellence network on microbiota and infectious diseases based on the Non-Human Primate (NHP) model. Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Cynbiose, a service company specializing in the development and commercialization of innovative preclinical models, today announces that it has procured financing of \u20ac1.9 million ($2.1M) under the third phase of the French Program \u2018Investment for the Future\u2019 (PiA3).<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32],"tags":[],"class_list":["post-17088","post","type-post","status-publish","format-standard","hentry","category-news","category-our-members"],"yoast_head":"\nCynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases - MabDesign<\/title>\n<meta name=\"description\" content=\"Cynbiose, a service company specializing in the development and commercialization of innovative preclinical models, today announces that it has procured financing of \u20ac1.9 million ($2.1M) under the third phase of the French Program \u2018Investment for the Future\u2019 (PiA3).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Cynbiose, a service company specializing in the development and commercialization of innovative preclinical models, today announces that it has procured financing of \u20ac1.9 million ($2.1M) under the third phase of the French Program \u2018Investment for the Future\u2019 (PiA3).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-28T10:02:45+00:00\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases\",\"datePublished\":\"2020-01-28T10:02:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/\"},\"wordCount\":79,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/\",\"name\":\"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"datePublished\":\"2020-01-28T10:02:45+00:00\",\"description\":\"Cynbiose, a service company specializing in the development and commercialization of innovative preclinical models, today announces that it has procured financing of \u20ac1.9 million ($2.1M) under the third phase of the French Program \u2018Investment for the Future\u2019 (PiA3).\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases - MabDesign","description":"Cynbiose, a service company specializing in the development and commercialization of innovative preclinical models, today announces that it has procured financing of \u20ac1.9 million ($2.1M) under the third phase of the French Program \u2018Investment for the Future\u2019 (PiA3).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/","og_locale":"en_US","og_type":"article","og_title":"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases - MabDesign","og_description":"Cynbiose, a service company specializing in the development and commercialization of innovative preclinical models, today announces that it has procured financing of \u20ac1.9 million ($2.1M) under the third phase of the French Program \u2018Investment for the Future\u2019 (PiA3).","og_url":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/","og_site_name":"MabDesign","article_published_time":"2020-01-28T10:02:45+00:00","author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases","datePublished":"2020-01-28T10:02:45+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/"},"wordCount":79,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/","url":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/","name":"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"datePublished":"2020-01-28T10:02:45+00:00","description":"Cynbiose, a service company specializing in the development and commercialization of innovative preclinical models, today announces that it has procured financing of \u20ac1.9 million ($2.1M) under the third phase of the French Program \u2018Investment for the Future\u2019 (PiA3).","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/cynbiose-receives-e1-9-million-2-1m-to-launch-cynbiome-preclinical-excellence-network-on-microbiome-and-infectious-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Cynbiose receives \u20ac1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=17088"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/17088\/revisions"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=17088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=17088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=17088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}